Immunovia Strengthens Management Team Ahead of its Commercial Launch of IMMrayTM PanCan-d
(WorldNews Denmark)

Immunovia Strengthens Management Team Ahead of its Commercial Launch of IMMrayTM PanCan-d LUND, SWEDEN - Immunovia AB (publ) (`Immunovia`) a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMrayTM for the early detection of cancer, today announced the strengthening of the Company`s management team with two very experienced executives. Hans Christian Pedersen has been appointed Vice -President of Business Development, succeeding Henrik Winther, and Dr. Peter Schultz-Knappe has been appointed Chief Technology Officer (CTO). Henrik Winther, Senior Vice-President of Business Development, is stepping...